Records containing: Minimal Residual Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-16Development and Validation of Non-Invasive Monitoring Techniques for Postoperative Recurrence and Novel Adjuvant Therapeutic Strategies in Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-03-20Infusion of Alloreactive nk Cells for Acute Myeloid Leukemia Patients, Eligible for Allogeneic Stem Cell Transplantiation, With Persistent Minimal Residual Disease After Conventional Chemotherapy
-
CLINICAL_TRIALS study record update · 2025-01-17First in Human Phase 1 Trial of ELI-002 Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-01-08NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
-
CLINICAL_TRIALS study record update · 2025-01-07Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-17A Case-Control Study To Determine The Suitability Of Artificial Intelligence For Leukemia Diagnostics
-
CLINICAL_TRIALS study record update · 2024-11-06Clinical Study on the Safety and Efficacy of QN-030a in Acute Myeloid Leukemia With Minimal Residual Disease
-
CLINICAL_TRIALS study record update · 2024-08-05A Study of VA Combined With PD-1 Inhibitor in the Treatment of Relapsed and Refractory AML and High-risk MDS
-
CLINICAL_TRIALS study record update · 2024-07-05A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
-
CLINICAL_TRIALS study record update · 2024-07-05LCCC 2103: Development and Application of a Novel Digital Array PCR Assay for Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia (AML)
-
CLINICAL_TRIALS study record update · 2024-06-24Comparing the Efficacy and Safety of Autologous Hematopoietic Stem-cell Transplantation Versus Non Transplantation Regimen in Primary Multiple Myeloma Achieved MRD Negativity After Induction: A Multiple Center, Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2024-05-08Dynamic ctDNA Detection for Guiding Adjuvant Therapy and Recurrence Monitoring After Curative Resection of Colorectal Cancer Liver Metastases: A Prospective Study
-
CLINICAL_TRIALS study record update · 2024-04-10A Multicentric, Prospective Study Addressing the Kinetics and Impact on Survival of Measurable Residual Disease in Acute Myeloid Leukemia Patients Receiving Azacitidine and Venetoclax
-
CLINICAL_TRIALS study record update · 2024-03-21Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA
-
CLINICAL_TRIALS study record update · 2024-03-01French Assessment of Minimal Residual Disease by Liquid Biopsies in Colorectal With Liver Metastasis Patients
-
CLINICAL_TRIALS study record update · 2024-01-16A Phase II Study of Blincyto in Children With CD19+ Precursor B-lineage ALL and MRD-Positivity Before and/or Following First Allogeneic HSCT
-
CLINICAL_TRIALS study record update · 2023-10-27A Study of Chidamide With AZA in MRD Positive AML After Transplant
-
CLINICAL_TRIALS study record update · 2023-09-08Characterising Tumour and Immune Cell Mobilisation Into Blood in Response to Acute Exercise in Chronic Lymphocytic Leukaemia
-
CLINICAL_TRIALS study record update · 2023-08-21Phase I/II Study of Dual CD19-CD22 Chimeric Antigen Receptor (CAR) T Cells in Patients With Advanced CD19+ CD22+ Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2023-08-21Treatment of MDS/AML Patients With an Impending Hematological Relapse With Azacitidine Alone or in Combination With PEvonedistat - a Randomized Phase 2 Trial
-
CLINICAL_TRIALS study record update · 2023-08-01Predicting the Efficacy and Prognosis of Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Based on Circulating Tumor DNA-minimal Residual Disease Technology : A Prospective, Observational Study
-
CLINICAL_TRIALS study record update · 2023-07-19Minimal Residual Disease Guided Radical Chemoradiotherapy Combined With Immunotherapy After Neoadjuvant Immunochemotherapy Followed by Adjuvant Immunotherapy for Esophageal Squamous Cell Cancer
-
CLINICAL_TRIALS study record update · 2023-06-28Cord Blood Ex-Vivo MSC Expansion Plus Fucosylation to Enhance Homing and Engraftment
-
CLINICAL_TRIALS study record update · 2023-06-26Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
-
CLINICAL_TRIALS study record update · 2023-06-12Efficacy Evaluation and Recurrence Monitoring of Neoadjuvant Therapy and Adjuvant Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.